APA (7th ed.) Citation

Wasan, H. S., Springett, G. M., Chodkiewicz, C., Wong, R., Maurel, J., Barone, C., . . . Spano, J. (2009). CA 19-9 as a biomarker in advanced pancreatic cancer patients randomised to gemcitabine plus axitinib or gemcitabine alone. British Journal of Cancer, 101(7), 1162. https://doi.org/10.1038/sj.bjc.6605243

Chicago Style (17th ed.) Citation

Wasan, H. S., et al. "CA 19-9 as a Biomarker in Advanced Pancreatic Cancer Patients Randomised to Gemcitabine Plus Axitinib or Gemcitabine Alone." British Journal of Cancer 101, no. 7 (2009): 1162. https://doi.org/10.1038/sj.bjc.6605243.

MLA (9th ed.) Citation

Wasan, H. S., et al. "CA 19-9 as a Biomarker in Advanced Pancreatic Cancer Patients Randomised to Gemcitabine Plus Axitinib or Gemcitabine Alone." British Journal of Cancer, vol. 101, no. 7, 2009, p. 1162, https://doi.org/10.1038/sj.bjc.6605243.